Protection against thrombosis in mice lacking PAR3

Ethan J. Weiss, Justin R. Hamilton, Katy E. Lease, Shaun R. Coughlin

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

The recent observation that knock-out of protease-activated receptor-4 (PAR4) ablates thrombin signaling in mouse platelets and protects against ferric chloride-induced thrombosis of mouse mesenteric arterioles suggests that thrombin's actions on platelets can play an important role in thrombosis. Complete ablation of thrombin signaling would be difficult to achieve in human beings because human platelets have 2 thrombin receptors that are each capable of mediating transmembrane signaling. However, it is possible that complete ablation of thrombin signaling in platelets is not necessary for an antithrombotic effect. In mouse platelets, PAR3 functions as a cofactor that binds thrombin and promotes productive cleavage of PAR4, and thrombin responses are decreased but not absent in Par3 -/- platelets. We now report that Par3 -/- mice were protected against ferric chloride-induced thrombosis of mesenteric arterioles and against thromboplastin-induced pulmonary embolism. Surprisingly, Par3 -/- and Par4 -/- mice showed similar degrees of protection in these models and similar prolongation of tail bleeding times. Thus, even a partial decrease in mouse platelet responsiveness to thrombin protected against thrombosis and impaired hemostasis in some settings. These results demonstrate the importance of PAR3's unusual cofactor function and underscore the relative importance of thrombin's actions on platelets in vivo. They also suggest that PAR inhibition might be explored for the prevention or treatment of thrombosis in human beings.

Original languageEnglish (US)
Pages (from-to)3240-3244
Number of pages5
JournalBlood
Volume100
Issue number9
DOIs
StatePublished - Nov 1 2002

Fingerprint

Platelets
Thrombin
Thrombosis
Blood Platelets
Arterioles
Ablation
Thrombin Receptors
Bleeding Time
Thromboplastin
Hemostasis
Pulmonary Embolism
Tail

ASJC Scopus subject areas

  • Hematology

Cite this

Weiss, E. J., Hamilton, J. R., Lease, K. E., & Coughlin, S. R. (2002). Protection against thrombosis in mice lacking PAR3. Blood, 100(9), 3240-3244. https://doi.org/10.1182/blood-2002-05-1470

Protection against thrombosis in mice lacking PAR3. / Weiss, Ethan J.; Hamilton, Justin R.; Lease, Katy E.; Coughlin, Shaun R.

In: Blood, Vol. 100, No. 9, 01.11.2002, p. 3240-3244.

Research output: Contribution to journalArticle

Weiss, EJ, Hamilton, JR, Lease, KE & Coughlin, SR 2002, 'Protection against thrombosis in mice lacking PAR3', Blood, vol. 100, no. 9, pp. 3240-3244. https://doi.org/10.1182/blood-2002-05-1470
Weiss, Ethan J. ; Hamilton, Justin R. ; Lease, Katy E. ; Coughlin, Shaun R. / Protection against thrombosis in mice lacking PAR3. In: Blood. 2002 ; Vol. 100, No. 9. pp. 3240-3244.
@article{c905e6abe4194e90acb81fe454c11428,
title = "Protection against thrombosis in mice lacking PAR3",
abstract = "The recent observation that knock-out of protease-activated receptor-4 (PAR4) ablates thrombin signaling in mouse platelets and protects against ferric chloride-induced thrombosis of mouse mesenteric arterioles suggests that thrombin's actions on platelets can play an important role in thrombosis. Complete ablation of thrombin signaling would be difficult to achieve in human beings because human platelets have 2 thrombin receptors that are each capable of mediating transmembrane signaling. However, it is possible that complete ablation of thrombin signaling in platelets is not necessary for an antithrombotic effect. In mouse platelets, PAR3 functions as a cofactor that binds thrombin and promotes productive cleavage of PAR4, and thrombin responses are decreased but not absent in Par3 -/- platelets. We now report that Par3 -/- mice were protected against ferric chloride-induced thrombosis of mesenteric arterioles and against thromboplastin-induced pulmonary embolism. Surprisingly, Par3 -/- and Par4 -/- mice showed similar degrees of protection in these models and similar prolongation of tail bleeding times. Thus, even a partial decrease in mouse platelet responsiveness to thrombin protected against thrombosis and impaired hemostasis in some settings. These results demonstrate the importance of PAR3's unusual cofactor function and underscore the relative importance of thrombin's actions on platelets in vivo. They also suggest that PAR inhibition might be explored for the prevention or treatment of thrombosis in human beings.",
author = "Weiss, {Ethan J.} and Hamilton, {Justin R.} and Lease, {Katy E.} and Coughlin, {Shaun R.}",
year = "2002",
month = "11",
day = "1",
doi = "10.1182/blood-2002-05-1470",
language = "English (US)",
volume = "100",
pages = "3240--3244",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

TY - JOUR

T1 - Protection against thrombosis in mice lacking PAR3

AU - Weiss, Ethan J.

AU - Hamilton, Justin R.

AU - Lease, Katy E.

AU - Coughlin, Shaun R.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - The recent observation that knock-out of protease-activated receptor-4 (PAR4) ablates thrombin signaling in mouse platelets and protects against ferric chloride-induced thrombosis of mouse mesenteric arterioles suggests that thrombin's actions on platelets can play an important role in thrombosis. Complete ablation of thrombin signaling would be difficult to achieve in human beings because human platelets have 2 thrombin receptors that are each capable of mediating transmembrane signaling. However, it is possible that complete ablation of thrombin signaling in platelets is not necessary for an antithrombotic effect. In mouse platelets, PAR3 functions as a cofactor that binds thrombin and promotes productive cleavage of PAR4, and thrombin responses are decreased but not absent in Par3 -/- platelets. We now report that Par3 -/- mice were protected against ferric chloride-induced thrombosis of mesenteric arterioles and against thromboplastin-induced pulmonary embolism. Surprisingly, Par3 -/- and Par4 -/- mice showed similar degrees of protection in these models and similar prolongation of tail bleeding times. Thus, even a partial decrease in mouse platelet responsiveness to thrombin protected against thrombosis and impaired hemostasis in some settings. These results demonstrate the importance of PAR3's unusual cofactor function and underscore the relative importance of thrombin's actions on platelets in vivo. They also suggest that PAR inhibition might be explored for the prevention or treatment of thrombosis in human beings.

AB - The recent observation that knock-out of protease-activated receptor-4 (PAR4) ablates thrombin signaling in mouse platelets and protects against ferric chloride-induced thrombosis of mouse mesenteric arterioles suggests that thrombin's actions on platelets can play an important role in thrombosis. Complete ablation of thrombin signaling would be difficult to achieve in human beings because human platelets have 2 thrombin receptors that are each capable of mediating transmembrane signaling. However, it is possible that complete ablation of thrombin signaling in platelets is not necessary for an antithrombotic effect. In mouse platelets, PAR3 functions as a cofactor that binds thrombin and promotes productive cleavage of PAR4, and thrombin responses are decreased but not absent in Par3 -/- platelets. We now report that Par3 -/- mice were protected against ferric chloride-induced thrombosis of mesenteric arterioles and against thromboplastin-induced pulmonary embolism. Surprisingly, Par3 -/- and Par4 -/- mice showed similar degrees of protection in these models and similar prolongation of tail bleeding times. Thus, even a partial decrease in mouse platelet responsiveness to thrombin protected against thrombosis and impaired hemostasis in some settings. These results demonstrate the importance of PAR3's unusual cofactor function and underscore the relative importance of thrombin's actions on platelets in vivo. They also suggest that PAR inhibition might be explored for the prevention or treatment of thrombosis in human beings.

UR - http://www.scopus.com/inward/record.url?scp=0036838525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036838525&partnerID=8YFLogxK

U2 - 10.1182/blood-2002-05-1470

DO - 10.1182/blood-2002-05-1470

M3 - Article

C2 - 12384423

AN - SCOPUS:0036838525

VL - 100

SP - 3240

EP - 3244

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -